March 16, 2020 / 11:48 AM / 24 days ago

BRIEF-Protalix - Agreed To Conduct Feasibility Study With Kirin Holdings To Evaluate Production Of Novel Complex Protein Utilizing Procellex

March 16 (Reuters) - Protalix Biotherapeutics Inc:

* PROTALIX BIOTHERAPEUTICS - AGREED TO CONDUCT FEASIBILITY STUDY WITH KIRIN HOLDINGS TO EVALUATE PRODUCTION OF NOVEL COMPLEX PROTEIN UTILIZING PROCELLEX

* PROTALIX - KIRIN WILL PROVIDE RESEARCH FUNDING FOR CO’S SCIENTISTS TO CONDUCT CELL LINE ENGINEERING, PROTEIN EXPRESSION STUDIES ON TARGET PROTEIN Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below